# EDGAR Filing Document

**Accession Number:** 0002055592
**File Stem:** 0000000000-25-009634
**Filing Date:** 2025-9
**Character Count:** 8649
**Document Hash:** 19b6998115424cc1317fc465cf5992e3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-009634.hdr.sgml**: 20260114

**ACCESSION NUMBER**: 0000000000-25-009634

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250905

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Gemini Space Station, Inc.
- **CENTRAL INDEX KEY:** 0002055592
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-07728

**BUSINESS ADDRESS:**
- **STREET 1:** 600 THIRD AVENUE, 2ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016
- **BUSINESS PHONE:** (646) 751-4401

**MAIL ADDRESS:**
- **STREET 1:** 600 THIRD AVENUE, 2ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001104659-25-013949

## Text-Extract

```

                                                            September 5, 2025

Tyler Winklevoss
Chief Executive Officer
Gemini Space Station, Inc.
600 Third Avenue, 2nd Floor
New York, NY 10016

       Re: Gemini Space Station, Inc.
           Amendment No. 2 to Registration Statement on Form S-1
           Filed September 2, 2025
           File No. 333-289665
Dear Tyler Winklevoss:

     We have reviewed your amended registration statement and have the
following
comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our August 28,
2025 letter.

Amendment No. 2 to Registration Statement on Form S-1
Risk Factors
Our amended and restated articles of incorporation will provide that the Eighth
Judicial
District Court of Clark County, Nevada..., page 80

1.     We note your revised disclosure in response to prior comment 2. Please
revise your
       disclosure here and on pages 186 - 187 to address the following:
           Please consider streamlining your disclosure in the first two
paragraphs of this
           risk factor, as much of the information appears redundant. In this
regard, both
           paragraphs appear to summarize Section 11.1 of the form of Amended
and
           Restated Articles of Incorporation, although the second paragraph
appears to be
           more consistent with the contents of Section 11.1. Please revise as
appropriate.
           Section 11.1 of the form of Amended and Restated Articles of
Incorporation states
 September 5, 2025
Page 2

           that the "exclusive forum provisions will not apply to suits brought
to enforce any
           liability or duty created by the Exchange Act or any other claim for
which the
           federal courts have exclusive jurisdiction" (emphasis added),
consistent with your
           disclosure in the second paragraph of this risk factor. However, in
the first
           paragraph of this risk factor, you disclose that the "exclusive
forum provisions
           will not apply to suits brought to enforce any liability or duty
created by the
           Securities Act or the Securities Exchange Act of 1934 ..., or to any
claim for which
           the U.S. federal courts have exclusive jurisdiction" (emphasis
added). Please
           revise your disclosure to reconcile this inconsistency.
             Please expand your disclosure to describe Section 11.2 of the form
of Amended
           and Restated Articles of Incorporation.
             We note that Section 11.2 of the form of Amended and Restated
Articles of
           Incorporation states that "[u]nless the Corporation consents in
writing to the
           selection of an alternative forum, the federal district courts of
the United States
           shall be the sole and exclusive forum for the resolution of any
claim asserting a
           cause of action arising under the Securities Act of 1933, as
amended, against any
           person in connection with any offering of the Corporation's
securities, including,
           for the avoidance of doubt, any auditor, underwriter, expert,
control person, or
           other defendant, which person shall have the right to enforce this
clause." Please
           revise your disclosure to address any uncertainty around the
enforceability of this
           provision, given the concurrent jurisdiction provided in Section 22
of the
           Securities Act. Relatedly, we note your statement in the penultimate
sentence of
           the second paragraph of this risk factor that, "[h]owever, Section
22 of the
           Securities Act creates concurrent jurisdiction for federal and state
courts over all
           suits brought to enforce a duty or liability created by the
Securities Act or the
           rules and regulations thereunder and, accordingly, we cannot be
certain that a
           court would enforce such provision." It appears that you may have
intended to
           refer to the forum selection provision specified in Section 11.2,
rather than in
           Section 11.1, with respect to this sentence. Please revise or
advise.
Capitalization, page 92

2.     Given the changes in your capitalization as a result of the Transactions
and the
       Additional Borrowings, please include explanatory notes to explain the
adjustments
       reflected in the pro forma amounts. For example, define the term
"Additional
       Borrowings," including a description of the significant terms of the
borrowings, and
       explain the changes to your cash and cash equivalents. In your response,
please clarify
       how the pro forma adjustments made to your capitalization table relate
to the pro
       forma adjustments described on page 15 in your summary historical
consolidated
       financial data. Additionally, please explain how your adjustment to
reflect the
       conversion of approximately $788 million of convertible notes and
convertible term
       loans reconciles to your disclosure on page 12 which discusses the
conversion
       of approximately $695.6 million of convertible notes and convertible
term loans.
 September 5, 2025
Page 3
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Quarterly Key Business Metrics, page 117

3.     We note your disclosure of exchange revenue by crypto asset for the one
month
       period ended July 2025 and 2024. Tell us what consideration you gave to
balancing
       this disclosure by also providing exchange operating expenses or profit
for the same
       one month periods.
Description of Capital Stock
Provisions of our Amended and Restated Articles of Incorporation and Amended
and
Restated Bylaws, page 185

4.     We note your revised disclosure in response to prior comment 8 that the
limited jury
       waiver provision in your amended and restated articles of incorporation
is intended to
       apply to any and all "internal actions" (as defined in NRS 78.046) to
the fullest extent
       not inconsistent with any applicable U.S. federal laws (including the
Securities Act
       and the Exchange Act). Please further revise your disclosure here and on
pages 80
       81 to clearly state whether such provision applies to claims under the
Securities Act or
       the Exchange Act. If not, please also ensure that the limited jury
waiver provision in
       your amended and restated articles of incorporation states this clearly,
or tell us how
       you will inform investors in future filings that the provision does not
apply to any
       actions arising under the Securities Act or Exchange Act.

       Please contact Kate Tillan at 202-551-3604 or Robert Telewicz at
202-551-3438 if
you have questions regarding comments on the financial statements and related
matters. Please contact David Lin at 202-551-3552 or Irene Paik at 202-551-6553
with any
other questions.

                                                            Sincerely,

                                                            Division of
Corporation Finance
                                                            Office of Crypto
Assets
cc:   Ryan J. Dzierniejko

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._